This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Learn what retirement accounts you should use at 50. Choosing wisely can secure your financial freedom.
25,328 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Rigetti Computing stock surged as government funding boosted optimism for quantum tech. Learn what happened, what it ...
June 2026 looked like a milestone month for Oklo, but the stock went the other way. This deep dive explains why the s...
The Trade Desk slid again amid reports of agency cautions and analyst downgrades. This piece explains the drivers, wh...
So-Young's Q1 2026 results offer clues about growth momentum and profitability. This article breaks down the numbers,...
A calmer catastrophe year can boost underwriting margins and reserve efficiency. This piece explains why allstate hav...
Lumentum Holdings stock zoomed after a positive investor briefing at a major industry conference and a rising price t...
IMAX stock jumped this week as takeover chatter surfaced. This article breaks down the drivers behind the move, what ...
Strategy disrupted the market by using Bitcoin as a cash engine. The recent $216 million sale to fund dividends promp...
Rivian stock rallied today as investors weighed new partnerships, production progress, and autonomous-driving milesto...
A major stake move by Arnhold LLC in Kyndryl Holdings has turned heads. This article breaks down what the purchase me...
A high-profile insider sale at CoreWeave has sparked questions about the company’s trajectory. This guide explains wh...